EPO Patents = 1

Forward Citations = 35

Loading Chart...

8 inventors (with patents filed for the assignee):

David S Casebier (4 out of 38 patents)

Vincent C O Njar (2 out of 15 patents)

Douglas B Jacoby (2 out of 12 patents)

4. Amina Zoubeidi (2 out of 4 patents)

5. Karen Ferrante (2 out of 2 patents)

6. Eva Corey (2 out of 2 patents)

7. Jodie Pope Morrison (2 out of 2 patents)

8. Cy Aaron Stein (2 out of 9 patents)

6 patents: Sort by Forward Citations

1. 9808472 - Biomarkers for treatment of neoplastic disorders using androgen-targeted therapies (2017-11-07),

2. 9387216 - Biomarkers for treatment of neoplastic disorders using androgen-targeted therapies (2016-07-12),

3. 9359395 - Prodrugs of steroidal CYP17 inhibitors/antiandrogens (2016-06-07),

4. 9156878 - Treatment of prostate cancer (2015-10-13),

5. 8791095 - Steroidal CYP17 inhibitors/antiandrogens (2014-07-29),

6. 8791094 - Treatment of prostate cancer (2014-07-29),

Tokai Pharmaceuticals, Inc. is a biopharmaceutical company focused on developing innovative therapies for prostate cancer and other hormone-driven diseases. They are dedicated to improving the lives of patients through the advancement of novel treatments.

This text is generated by artificial intelligence and may not be accurate.

Company Badge

USPTO Data Jan 1 1976 - Dec 9 2025

6 Patents

#269 in Boston, MA

#2,472 in Massachusetts

#43,751 in US

Boston, MA, United States of America

Tokai Pharmaceuticals, Inc.